{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:09:49Z","timestamp":1779340189243,"version":"3.51.4"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>\n                    The optimal management of non-flow-limiting coronary dissection after drug-coated balloon (DCB) angioplasty remains controversial, particularly in Asian populations. We conducted a prospective, three-arm cohort study to evaluate whether conservative management of non-flow-limiting dissection is non-inferior to bailout stent in patients with\n                    <jats:italic>de novo<\/jats:italic>\n                    medium-to-large coronary artery lesions. A total of 276 patients treated with DCB at Shaoxing Central Hospital were enrolled and divided into three Arms: conservative management for non-flow-limiting dissection (Arm 1,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200991), bailout stent for dissection (Arm 2,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200993), and none dissection (Arm 3,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200982). The primary endpoint was 12-month major adverse cardiovascular events (MACE), including cardiac death, target vessel myocardial infarction, and clinically driven target lesion revascularization. Secondary endpoints included BARC 3\u20135 bleeding, all-cause death, recurrent angina, and ischemic stroke. At 12-month follow-up, the incidence of MACE was 7.7% (7\/91) in the conservative management arm, 6.4% (6\/93) in the bailout stent arm, and 5.4% (5\/92) in the no-dissection control arm (Log-rank\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&amp;gt;\u20090.05). The absolute risk difference (ARD) between conservative and bailout stent arms was 1.3% (95% CI: \u22124.2% to 6.8%). Since the upper 95% CI limit (6.8%) was below the prespecified 10% non-inferiority margin, non-inferiority was confirmed. The corresponding HR was 1.13 (95% CI: 0.58\u20132.19,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&amp;gt;\u20090.05). No significant between-group differences were observed in any secondary clinical endpoints (all\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&amp;gt;\u20090.05). Multivariable Cox proportional-hazards regression analysis demonstrated that dissection management strategy was not an independent predictor of 12-month MACE (adjusted HR 1.12, 95% CI: 0.38\u20132.21,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&amp;gt;\u20090.05). Prespecified subgroup and sensitivity analyses yielded consistent results with no significant interaction effects (all\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&amp;gt;\u20090.05). In conclusion, conservative management of non-flow-limiting NHLBI type A\u2013C dissection after DCB angioplasty for\n                    <jats:italic>de novo<\/jats:italic>\n                    medium-to-large coronary lesions is non-inferior to bailout stenting for 12-month MACE in an Asian population, with clinical outcomes comparable to those of patients without dissection. Routine bailout stenting may be considered optional in this clinical setting. These findings suggest the potential value of conservative management as an alternative DCB-only strategy, within the pilot and exploratory nature of this study.\n                  <\/jats:p>","DOI":"10.3389\/fcvm.2026.1821342","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:36:07Z","timestamp":1779338167000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Conservative management without routine bailout stent for non-flow-limiting dissection after DCB angioplasty: a prospective three-arm study"],"prefix":"10.3389","volume":"13","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shaoxing Central Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dewen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing Central Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailiang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing Central Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanben","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing Central Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing Central Hospital","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1159\/000547099","article-title":"Efficacy of drug-coated balloon versus drug-eluting stent for patients with de novo coronary artery disease: a systematic review and meta-analysis","volume":"34","author":"Haq","year":"2025","journal-title":"Med Princ Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ccd.27359","article-title":"Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: a systematic review and meta-analysis","volume":"92","author":"Kokkinidis","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e036839","DOI":"10.1161\/JAHA.124.036839","article-title":"Drug-coated balloons versus drug-eluting stents or plain old balloon angioplasty: a long-term in-stent restenosis study","volume":"13","author":"Von Koch","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10557-020-07008-7","article-title":"Impact of PRECISE-DAPT and DAPT scores on dual antiplatelet therapy duration after 2nd generation drug-eluting stent implantation","volume":"35","author":"Jang","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1396","DOI":"10.4244\/EIJ-E-25-00049","article-title":"Do we still need more data to adopt a short duration of DAPT routinely following PCI in high bleeding risk patients?","volume":"21","author":"Marquis-Gravel","year":"2025","journal-title":"EuroIntervention"},{"key":"B6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12928-019-00571-3","article-title":"Clinical and angiographic outcomes of coronary dissection after paclitaxel-coated balloon angioplasty for small vessel coronary artery disease","volume":"34","author":"Funatsu","year":"2019","journal-title":"Cardiovasc Interv Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4158363","DOI":"10.1155\/2020\/4158363","article-title":"Drug-coated balloon for de novo coronary artery lesions: a systematic review and trial sequential meta-analysis of randomized controlled trials","volume":"2020","author":"Liu","year":"2020","journal-title":"Cardiovasc Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.amjcard.2024.12.008","article-title":"Coronary artery dissection in drug-coated balloon angioplasty: incidence, predictors, and clinical outcomes","volume":"239","author":"Gitto","year":"2025","journal-title":"Am J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCA.0000000000000926","article-title":"Spontaneous coronary artery dissection: presentation and management options","volume":"32","author":"Kermali","year":"2021","journal-title":"Coron Artery Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.hjc.2021.02.013","article-title":"Invasive versus conservative management in spontaneous coronary artery dissection: a meta-analysis and meta-regression study","volume":"62","author":"Bocchino","year":"2021","journal-title":"Hellenic J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ccd.30906","article-title":"The fate of coronary dissections left after sirolimus-coated balloon angioplasty: a prespecified subanalysis of the EASTBOURNE study","volume":"102","author":"El Khoury","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.33963\/KP.15554","article-title":"Successful bailout T-stenting for iatrogenic coronary dissection involving left main stem bifurcation: \u201cfirst, do no harm\u201d","volume":"78","author":"Kassimis","year":"2020","journal-title":"Kardiol Pol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s00059-016-4502-9","article-title":"Safety of bailout stenting after paclitaxel-coated balloon angioplasty","volume":"42","author":"Mok","year":"2017","journal-title":"Herz"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.jcin.2015.08.029","article-title":"Effect of drug-coated balloons in native coronary artery disease left with a dissection","volume":"8","author":"Cortese","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11886-025-02237-4","article-title":"Interventional management of intracoronary dissection\/hematoma: a comprehensive review","volume":"27","author":"Giannino","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jacasi.2025.02.017","article-title":"Drug-Coated balloons-based intervention for coronary artery disease: the second report of asia-pacific consensus group","volume":"5","author":"Her","year":"2025","journal-title":"JACC Asia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ijcard.2015.10.156","article-title":"Healing after coronary artery dissection: the effect of a drug coated balloon angioplasty in a bifurcation lesion. A lesson from intravascular ultrasound analysis","volume":"203","author":"Piraino","year":"2016","journal-title":"Int J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B19","first-page":"493","article-title":"Coronary artery dissection and perforation complicating percutaneous coronary intervention","volume":"16","author":"Rogers","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1090","DOI":"10.4244\/EIJ-D-19-00202","article-title":"Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial","volume":"15","author":"Serruys","year":"2019","journal-title":"EuroIntervention"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/medicina61081470","article-title":"Coronary angioplasty with drug-coated balloons: pharmacological foundations, clinical efficacy, and future directions","volume":"61","author":"Chioncel","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e000117","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"key":"B23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/MCA.0000000000001189","article-title":"Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography","volume":"33","author":"McInerney","year":"2022","journal-title":"Coron Artery Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1253\/circj.CJ-13-0786","article-title":"Epidemiology of stroke and coronary artery disease in Asia","volume":"77","author":"Hata","year":"2013","journal-title":"Circ J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/jcm12031238","article-title":"Stent thrombosis and restenosis with contemporary drug-eluting stents: predictors and current evidence","volume":"12","author":"Condello","year":"2023","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MCA.0000000000000552","article-title":"Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis","volume":"29","author":"Fukushima","year":"2018","journal-title":"Coron Artery Dis"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1821342\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:36:29Z","timestamp":1779338189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1821342\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":26,"alternative-id":["10.3389\/fcvm.2026.1821342"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1821342","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1821342"}}